nodes	percent_of_prediction	percent_of_DWPC	metapath
Sildenafil—CYP2E1—lung cancer	0.141	0.503	CbGaD
Sildenafil—CYP1A1—lung cancer	0.139	0.497	CbGaD
Sildenafil—ABCC10—Gemcitabine—lung cancer	0.0474	0.0988	CbGbCtD
Sildenafil—ABCC10—Paclitaxel—lung cancer	0.0428	0.0893	CbGbCtD
Sildenafil—ABCC5—Cisplatin—lung cancer	0.0344	0.0718	CbGbCtD
Sildenafil—ABCC10—Etoposide—lung cancer	0.0338	0.0705	CbGbCtD
Sildenafil—ABCC10—Docetaxel—lung cancer	0.031	0.0645	CbGbCtD
Sildenafil—ABCC10—Doxorubicin—lung cancer	0.0231	0.0481	CbGbCtD
Sildenafil—ABCC10—Methotrexate—lung cancer	0.0224	0.0466	CbGbCtD
Sildenafil—CYP1A1—Gefitinib—lung cancer	0.0189	0.0393	CbGbCtD
Sildenafil—CYP3A5—Gefitinib—lung cancer	0.0113	0.0236	CbGbCtD
Sildenafil—CYP1A1—Erlotinib—lung cancer	0.0112	0.0233	CbGbCtD
Sildenafil—CYP3A5—Teniposide—lung cancer	0.011	0.0229	CbGbCtD
Sildenafil—ABCC4—Methotrexate—lung cancer	0.0107	0.0224	CbGbCtD
Sildenafil—CYP2C19—Gefitinib—lung cancer	0.00913	0.019	CbGbCtD
Sildenafil—CYP2C19—Teniposide—lung cancer	0.00886	0.0185	CbGbCtD
Sildenafil—CYP3A7-CYP3A51P—Paclitaxel—lung cancer	0.00817	0.017	CbGbCtD
Sildenafil—CYP3A7—Paclitaxel—lung cancer	0.00817	0.017	CbGbCtD
Sildenafil—CYP3A7—Irinotecan—lung cancer	0.00806	0.0168	CbGbCtD
Sildenafil—CYP3A7-CYP3A51P—Irinotecan—lung cancer	0.00806	0.0168	CbGbCtD
Sildenafil—CYP2C9—Gefitinib—lung cancer	0.00759	0.0158	CbGbCtD
Sildenafil—CYP2C9—Teniposide—lung cancer	0.00736	0.0154	CbGbCtD
Sildenafil—CYP2D6—Gefitinib—lung cancer	0.00694	0.0145	CbGbCtD
Sildenafil—CYP3A5—Crizotinib—lung cancer	0.00694	0.0145	CbGbCtD
Sildenafil—CYP3A5—Erlotinib—lung cancer	0.0067	0.014	CbGbCtD
Sildenafil—CYP2E1—Etoposide—lung cancer	0.00623	0.013	CbGbCtD
Sildenafil—CYP3A5—Paclitaxel—lung cancer	0.00613	0.0128	CbGbCtD
Sildenafil—CYP3A5—Irinotecan—lung cancer	0.00605	0.0126	CbGbCtD
Sildenafil—CYP3A7—Docetaxel—lung cancer	0.00591	0.0123	CbGbCtD
Sildenafil—CYP3A7-CYP3A51P—Docetaxel—lung cancer	0.00591	0.0123	CbGbCtD
Sildenafil—CYP2D6—Vinorelbine—lung cancer	0.00535	0.0112	CbGbCtD
Sildenafil—PDE5A—pulmonary artery—lung cancer	0.00508	0.255	CbGeAlD
Sildenafil—CYP3A5—Etoposide—lung cancer	0.00484	0.0101	CbGbCtD
Sildenafil—CYP3A4—Topotecan—lung cancer	0.00483	0.0101	CbGbCtD
Sildenafil—CYP3A5—Docetaxel—lung cancer	0.00443	0.00924	CbGbCtD
Sildenafil—CYP3A4—Gefitinib—lung cancer	0.00442	0.00921	CbGbCtD
Sildenafil—CYP3A4—Teniposide—lung cancer	0.00428	0.00893	CbGbCtD
Sildenafil—CYP2C9—Paclitaxel—lung cancer	0.00411	0.00857	CbGbCtD
Sildenafil—CYP2D6—Erlotinib—lung cancer	0.00411	0.00856	CbGbCtD
Sildenafil—CYP3A4—Vinorelbine—lung cancer	0.0034	0.00709	CbGbCtD
Sildenafil—CYP2C9—Cisplatin—lung cancer	0.00331	0.00689	CbGbCtD
Sildenafil—CYP2D6—Vinblastine—lung cancer	0.0033	0.00687	CbGbCtD
Sildenafil—CYP3A4—Crizotinib—lung cancer	0.00271	0.00564	CbGbCtD
Sildenafil—CYP3A4—Erlotinib—lung cancer	0.00261	0.00544	CbGbCtD
Sildenafil—CYP3A4—Paclitaxel—lung cancer	0.00239	0.00498	CbGbCtD
Sildenafil—CYP3A4—Irinotecan—lung cancer	0.00236	0.00492	CbGbCtD
Sildenafil—CYP3A4—Vinblastine—lung cancer	0.0021	0.00437	CbGbCtD
Sildenafil—CYP2D6—Doxorubicin—lung cancer	0.00203	0.00422	CbGbCtD
Sildenafil—CYP3A4—Etoposide—lung cancer	0.00189	0.00394	CbGbCtD
Sildenafil—CYP3A4—Docetaxel—lung cancer	0.00173	0.0036	CbGbCtD
Sildenafil—CYP3A4—Doxorubicin—lung cancer	0.00129	0.00269	CbGbCtD
Sildenafil—ABCC5—mammary gland—lung cancer	0.00117	0.0588	CbGeAlD
Sildenafil—PDE6G—lung—lung cancer	0.00115	0.0576	CbGeAlD
Sildenafil—PDE5A—respiratory system—lung cancer	0.000854	0.0429	CbGeAlD
Sildenafil—PDE6G—lymph node—lung cancer	0.000785	0.0394	CbGeAlD
Sildenafil—PDE5A—epithelium—lung cancer	0.000714	0.0358	CbGeAlD
Sildenafil—ABCC5—bronchus—lung cancer	0.000643	0.0323	CbGeAlD
Sildenafil—ABCC5—cardiac atrium—lung cancer	0.000542	0.0272	CbGeAlD
Sildenafil—ABCC10—bronchus—lung cancer	0.000537	0.027	CbGeAlD
Sildenafil—CYP2C9—mammary gland—lung cancer	0.000524	0.0263	CbGeAlD
Sildenafil—ABCC10—trachea—lung cancer	0.000482	0.0242	CbGeAlD
Sildenafil—ABCC5—bone marrow—lung cancer	0.000458	0.023	CbGeAlD
Sildenafil—PDE5A—lung—lung cancer	0.000454	0.0228	CbGeAlD
Sildenafil—ABCC10—cardiac atrium—lung cancer	0.000453	0.0227	CbGeAlD
Sildenafil—ABCC4—bronchus—lung cancer	0.000446	0.0224	CbGeAlD
Sildenafil—ABCC5—lung—lung cancer	0.000415	0.0208	CbGeAlD
Sildenafil—ABCC10—bone marrow—lung cancer	0.000383	0.0192	CbGeAlD
Sildenafil—CYP1A1—respiratory system—lung cancer	0.000363	0.0182	CbGeAlD
Sildenafil—CYP3A5—respiratory system—lung cancer	0.000355	0.0178	CbGeAlD
Sildenafil—ABCC10—lung—lung cancer	0.000347	0.0174	CbGeAlD
Sildenafil—CYP2E1—respiratory system—lung cancer	0.000331	0.0166	CbGeAlD
Sildenafil—ABCC4—bone marrow—lung cancer	0.000317	0.0159	CbGeAlD
Sildenafil—PDE5A—lymph node—lung cancer	0.00031	0.0156	CbGeAlD
Sildenafil—CYP1A1—epithelium—lung cancer	0.000303	0.0152	CbGeAlD
Sildenafil—CYP1A1—bronchus—lung cancer	0.000299	0.015	CbGeAlD
Sildenafil—ABCC4—lung—lung cancer	0.000288	0.0144	CbGeAlD
Sildenafil—ABCC5—lymph node—lung cancer	0.000284	0.0142	CbGeAlD
Sildenafil—CYP1A1—trachea—lung cancer	0.000268	0.0135	CbGeAlD
Sildenafil—CYP1A1—cardiac atrium—lung cancer	0.000252	0.0126	CbGeAlD
Sildenafil—ABCC10—lymph node—lung cancer	0.000237	0.0119	CbGeAlD
Sildenafil—ABCC4—lymph node—lung cancer	0.000197	0.00987	CbGeAlD
Sildenafil—CYP1A1—lung—lung cancer	0.000193	0.00967	CbGeAlD
Sildenafil—CYP3A5—lung—lung cancer	0.000188	0.00945	CbGeAlD
Sildenafil—CYP2E1—lung—lung cancer	0.000176	0.00882	CbGeAlD
Sildenafil—CYP1A1—lymph node—lung cancer	0.000132	0.00661	CbGeAlD
Sildenafil—Fatigue—Paclitaxel—lung cancer	3.81e-05	0.000261	CcSEcCtD
Sildenafil—Haemorrhage—Methotrexate—lung cancer	3.8e-05	0.000261	CcSEcCtD
Sildenafil—Pollakiuria—Doxorubicin—lung cancer	3.79e-05	0.00026	CcSEcCtD
Sildenafil—Asthenia—Gemcitabine—lung cancer	3.78e-05	0.00026	CcSEcCtD
Sildenafil—Pain—Paclitaxel—lung cancer	3.78e-05	0.000259	CcSEcCtD
Sildenafil—Constipation—Paclitaxel—lung cancer	3.78e-05	0.000259	CcSEcCtD
Sildenafil—Pharyngitis—Methotrexate—lung cancer	3.77e-05	0.000259	CcSEcCtD
Sildenafil—Urinary tract disorder—Methotrexate—lung cancer	3.75e-05	0.000257	CcSEcCtD
Sildenafil—Photosensitivity reaction—Doxorubicin—lung cancer	3.75e-05	0.000257	CcSEcCtD
Sildenafil—Oedema—Docetaxel—lung cancer	3.74e-05	0.000257	CcSEcCtD
Sildenafil—Weight increased—Doxorubicin—lung cancer	3.74e-05	0.000257	CcSEcCtD
Sildenafil—Pruritus—Gemcitabine—lung cancer	3.73e-05	0.000256	CcSEcCtD
Sildenafil—Urethral disorder—Methotrexate—lung cancer	3.72e-05	0.000255	CcSEcCtD
Sildenafil—Infection—Docetaxel—lung cancer	3.72e-05	0.000255	CcSEcCtD
Sildenafil—Feeling abnormal—Etoposide—lung cancer	3.71e-05	0.000255	CcSEcCtD
Sildenafil—Hyperglycaemia—Doxorubicin—lung cancer	3.71e-05	0.000254	CcSEcCtD
Sildenafil—Diarrhoea—Irinotecan—lung cancer	3.7e-05	0.000254	CcSEcCtD
Sildenafil—Pneumonia—Doxorubicin—lung cancer	3.68e-05	0.000253	CcSEcCtD
Sildenafil—Gastrointestinal pain—Etoposide—lung cancer	3.68e-05	0.000253	CcSEcCtD
Sildenafil—Shock—Docetaxel—lung cancer	3.68e-05	0.000253	CcSEcCtD
Sildenafil—Nervous system disorder—Docetaxel—lung cancer	3.67e-05	0.000252	CcSEcCtD
Sildenafil—Infestation NOS—Doxorubicin—lung cancer	3.66e-05	0.000251	CcSEcCtD
Sildenafil—Infestation—Doxorubicin—lung cancer	3.66e-05	0.000251	CcSEcCtD
Sildenafil—Visual impairment—Methotrexate—lung cancer	3.66e-05	0.000251	CcSEcCtD
Sildenafil—Tachycardia—Docetaxel—lung cancer	3.65e-05	0.000251	CcSEcCtD
Sildenafil—Feeling abnormal—Paclitaxel—lung cancer	3.64e-05	0.00025	CcSEcCtD
Sildenafil—Skin disorder—Docetaxel—lung cancer	3.64e-05	0.00025	CcSEcCtD
Sildenafil—Stevens-Johnson syndrome—Doxorubicin—lung cancer	3.63e-05	0.000249	CcSEcCtD
Sildenafil—Hypersensitivity—Cisplatin—lung cancer	3.62e-05	0.000249	CcSEcCtD
Sildenafil—Gastrointestinal pain—Paclitaxel—lung cancer	3.61e-05	0.000248	CcSEcCtD
Sildenafil—Diarrhoea—Gemcitabine—lung cancer	3.61e-05	0.000248	CcSEcCtD
Sildenafil—Renal failure—Doxorubicin—lung cancer	3.6e-05	0.000247	CcSEcCtD
Sildenafil—Erythema multiforme—Methotrexate—lung cancer	3.59e-05	0.000246	CcSEcCtD
Sildenafil—Neuropathy peripheral—Doxorubicin—lung cancer	3.59e-05	0.000246	CcSEcCtD
Sildenafil—Dizziness—Irinotecan—lung cancer	3.58e-05	0.000246	CcSEcCtD
Sildenafil—Urticaria—Etoposide—lung cancer	3.58e-05	0.000246	CcSEcCtD
Sildenafil—Stomatitis—Doxorubicin—lung cancer	3.57e-05	0.000245	CcSEcCtD
Sildenafil—Anorexia—Docetaxel—lung cancer	3.57e-05	0.000245	CcSEcCtD
Sildenafil—Abdominal pain—Etoposide—lung cancer	3.56e-05	0.000244	CcSEcCtD
Sildenafil—Body temperature increased—Etoposide—lung cancer	3.56e-05	0.000244	CcSEcCtD
Sildenafil—Conjunctivitis—Doxorubicin—lung cancer	3.56e-05	0.000244	CcSEcCtD
Sildenafil—Urinary tract infection—Doxorubicin—lung cancer	3.56e-05	0.000244	CcSEcCtD
Sildenafil—Eye disorder—Methotrexate—lung cancer	3.55e-05	0.000244	CcSEcCtD
Sildenafil—Tinnitus—Methotrexate—lung cancer	3.54e-05	0.000243	CcSEcCtD
Sildenafil—Asthenia—Cisplatin—lung cancer	3.53e-05	0.000242	CcSEcCtD
Sildenafil—Cardiac disorder—Methotrexate—lung cancer	3.52e-05	0.000242	CcSEcCtD
Sildenafil—Sweating—Doxorubicin—lung cancer	3.51e-05	0.000241	CcSEcCtD
Sildenafil—Urticaria—Paclitaxel—lung cancer	3.51e-05	0.000241	CcSEcCtD
Sildenafil—Hypotension—Docetaxel—lung cancer	3.5e-05	0.00024	CcSEcCtD
Sildenafil—Haematuria—Doxorubicin—lung cancer	3.49e-05	0.00024	CcSEcCtD
Sildenafil—Abdominal pain—Paclitaxel—lung cancer	3.49e-05	0.00024	CcSEcCtD
Sildenafil—Body temperature increased—Paclitaxel—lung cancer	3.49e-05	0.00024	CcSEcCtD
Sildenafil—Epistaxis—Doxorubicin—lung cancer	3.45e-05	0.000237	CcSEcCtD
Sildenafil—Angiopathy—Methotrexate—lung cancer	3.45e-05	0.000236	CcSEcCtD
Sildenafil—Vomiting—Irinotecan—lung cancer	3.44e-05	0.000236	CcSEcCtD
Sildenafil—Sinusitis—Doxorubicin—lung cancer	3.44e-05	0.000236	CcSEcCtD
Sildenafil—Immune system disorder—Methotrexate—lung cancer	3.43e-05	0.000235	CcSEcCtD
Sildenafil—Mediastinal disorder—Methotrexate—lung cancer	3.42e-05	0.000235	CcSEcCtD
Sildenafil—Rash—Irinotecan—lung cancer	3.41e-05	0.000234	CcSEcCtD
Sildenafil—Dermatitis—Irinotecan—lung cancer	3.41e-05	0.000234	CcSEcCtD
Sildenafil—Musculoskeletal discomfort—Docetaxel—lung cancer	3.41e-05	0.000234	CcSEcCtD
Sildenafil—Chills—Methotrexate—lung cancer	3.41e-05	0.000234	CcSEcCtD
Sildenafil—Headache—Irinotecan—lung cancer	3.39e-05	0.000233	CcSEcCtD
Sildenafil—Insomnia—Docetaxel—lung cancer	3.39e-05	0.000232	CcSEcCtD
Sildenafil—Diarrhoea—Cisplatin—lung cancer	3.36e-05	0.000231	CcSEcCtD
Sildenafil—Paraesthesia—Docetaxel—lung cancer	3.36e-05	0.000231	CcSEcCtD
Sildenafil—Alopecia—Methotrexate—lung cancer	3.36e-05	0.00023	CcSEcCtD
Sildenafil—Vomiting—Gemcitabine—lung cancer	3.35e-05	0.00023	CcSEcCtD
Sildenafil—Dyspnoea—Docetaxel—lung cancer	3.34e-05	0.000229	CcSEcCtD
Sildenafil—Somnolence—Docetaxel—lung cancer	3.33e-05	0.000228	CcSEcCtD
Sildenafil—Mental disorder—Methotrexate—lung cancer	3.33e-05	0.000228	CcSEcCtD
Sildenafil—Rash—Gemcitabine—lung cancer	3.33e-05	0.000228	CcSEcCtD
Sildenafil—Dermatitis—Gemcitabine—lung cancer	3.32e-05	0.000228	CcSEcCtD
Sildenafil—Hypersensitivity—Etoposide—lung cancer	3.32e-05	0.000228	CcSEcCtD
Sildenafil—Malnutrition—Methotrexate—lung cancer	3.31e-05	0.000227	CcSEcCtD
Sildenafil—Erythema—Methotrexate—lung cancer	3.31e-05	0.000227	CcSEcCtD
Sildenafil—Haemoglobin—Doxorubicin—lung cancer	3.3e-05	0.000227	CcSEcCtD
Sildenafil—Headache—Gemcitabine—lung cancer	3.3e-05	0.000227	CcSEcCtD
Sildenafil—Rhinitis—Doxorubicin—lung cancer	3.3e-05	0.000226	CcSEcCtD
Sildenafil—Dyspepsia—Docetaxel—lung cancer	3.3e-05	0.000226	CcSEcCtD
Sildenafil—Haemorrhage—Doxorubicin—lung cancer	3.29e-05	0.000226	CcSEcCtD
Sildenafil—Hypoaesthesia—Doxorubicin—lung cancer	3.27e-05	0.000225	CcSEcCtD
Sildenafil—Pharyngitis—Doxorubicin—lung cancer	3.26e-05	0.000224	CcSEcCtD
Sildenafil—Decreased appetite—Docetaxel—lung cancer	3.25e-05	0.000223	CcSEcCtD
Sildenafil—Hypersensitivity—Paclitaxel—lung cancer	3.25e-05	0.000223	CcSEcCtD
Sildenafil—Urinary tract disorder—Doxorubicin—lung cancer	3.25e-05	0.000223	CcSEcCtD
Sildenafil—Oedema peripheral—Doxorubicin—lung cancer	3.24e-05	0.000222	CcSEcCtD
Sildenafil—Gastrointestinal disorder—Docetaxel—lung cancer	3.23e-05	0.000222	CcSEcCtD
Sildenafil—Asthenia—Etoposide—lung cancer	3.23e-05	0.000222	CcSEcCtD
Sildenafil—Connective tissue disorder—Doxorubicin—lung cancer	3.23e-05	0.000222	CcSEcCtD
Sildenafil—Fatigue—Docetaxel—lung cancer	3.23e-05	0.000221	CcSEcCtD
Sildenafil—Urethral disorder—Doxorubicin—lung cancer	3.22e-05	0.000221	CcSEcCtD
Sildenafil—Nausea—Irinotecan—lung cancer	3.22e-05	0.000221	CcSEcCtD
Sildenafil—Constipation—Docetaxel—lung cancer	3.2e-05	0.00022	CcSEcCtD
Sildenafil—Pain—Docetaxel—lung cancer	3.2e-05	0.00022	CcSEcCtD
Sildenafil—Back pain—Methotrexate—lung cancer	3.2e-05	0.000219	CcSEcCtD
Sildenafil—Pruritus—Etoposide—lung cancer	3.19e-05	0.000219	CcSEcCtD
Sildenafil—Visual impairment—Doxorubicin—lung cancer	3.17e-05	0.000217	CcSEcCtD
Sildenafil—Asthenia—Paclitaxel—lung cancer	3.17e-05	0.000217	CcSEcCtD
Sildenafil—Nausea—Gemcitabine—lung cancer	3.13e-05	0.000215	CcSEcCtD
Sildenafil—Vomiting—Cisplatin—lung cancer	3.13e-05	0.000215	CcSEcCtD
Sildenafil—Pruritus—Paclitaxel—lung cancer	3.12e-05	0.000214	CcSEcCtD
Sildenafil—Vision blurred—Methotrexate—lung cancer	3.12e-05	0.000214	CcSEcCtD
Sildenafil—Erythema multiforme—Doxorubicin—lung cancer	3.11e-05	0.000213	CcSEcCtD
Sildenafil—Rash—Cisplatin—lung cancer	3.1e-05	0.000213	CcSEcCtD
Sildenafil—Dermatitis—Cisplatin—lung cancer	3.1e-05	0.000213	CcSEcCtD
Sildenafil—Feeling abnormal—Docetaxel—lung cancer	3.08e-05	0.000212	CcSEcCtD
Sildenafil—Diarrhoea—Etoposide—lung cancer	3.08e-05	0.000211	CcSEcCtD
Sildenafil—Eye disorder—Doxorubicin—lung cancer	3.07e-05	0.000211	CcSEcCtD
Sildenafil—Ill-defined disorder—Methotrexate—lung cancer	3.07e-05	0.00021	CcSEcCtD
Sildenafil—Tinnitus—Doxorubicin—lung cancer	3.07e-05	0.00021	CcSEcCtD
Sildenafil—Gastrointestinal pain—Docetaxel—lung cancer	3.06e-05	0.00021	CcSEcCtD
Sildenafil—Anaemia—Methotrexate—lung cancer	3.06e-05	0.00021	CcSEcCtD
Sildenafil—Cardiac disorder—Doxorubicin—lung cancer	3.05e-05	0.000209	CcSEcCtD
Sildenafil—Flushing—Doxorubicin—lung cancer	3.05e-05	0.000209	CcSEcCtD
Sildenafil—Diarrhoea—Paclitaxel—lung cancer	3.02e-05	0.000207	CcSEcCtD
Sildenafil—Angiopathy—Doxorubicin—lung cancer	2.98e-05	0.000205	CcSEcCtD
Sildenafil—Malaise—Methotrexate—lung cancer	2.98e-05	0.000205	CcSEcCtD
Sildenafil—Dizziness—Etoposide—lung cancer	2.98e-05	0.000204	CcSEcCtD
Sildenafil—Immune system disorder—Doxorubicin—lung cancer	2.97e-05	0.000204	CcSEcCtD
Sildenafil—Vertigo—Methotrexate—lung cancer	2.97e-05	0.000204	CcSEcCtD
Sildenafil—Mediastinal disorder—Doxorubicin—lung cancer	2.96e-05	0.000203	CcSEcCtD
Sildenafil—Abdominal pain—Docetaxel—lung cancer	2.96e-05	0.000203	CcSEcCtD
Sildenafil—Body temperature increased—Docetaxel—lung cancer	2.96e-05	0.000203	CcSEcCtD
Sildenafil—Leukopenia—Methotrexate—lung cancer	2.96e-05	0.000203	CcSEcCtD
Sildenafil—Chills—Doxorubicin—lung cancer	2.95e-05	0.000202	CcSEcCtD
Sildenafil—Arrhythmia—Doxorubicin—lung cancer	2.94e-05	0.000202	CcSEcCtD
Sildenafil—Dizziness—Paclitaxel—lung cancer	2.92e-05	0.0002	CcSEcCtD
Sildenafil—Nausea—Cisplatin—lung cancer	2.92e-05	0.0002	CcSEcCtD
Sildenafil—Alopecia—Doxorubicin—lung cancer	2.91e-05	0.000199	CcSEcCtD
Sildenafil—Cough—Methotrexate—lung cancer	2.88e-05	0.000198	CcSEcCtD
Sildenafil—Mental disorder—Doxorubicin—lung cancer	2.88e-05	0.000198	CcSEcCtD
Sildenafil—Convulsion—Methotrexate—lung cancer	2.86e-05	0.000197	CcSEcCtD
Sildenafil—Vomiting—Etoposide—lung cancer	2.86e-05	0.000197	CcSEcCtD
Sildenafil—Erythema—Doxorubicin—lung cancer	2.86e-05	0.000196	CcSEcCtD
Sildenafil—Malnutrition—Doxorubicin—lung cancer	2.86e-05	0.000196	CcSEcCtD
Sildenafil—Rash—Etoposide—lung cancer	2.84e-05	0.000195	CcSEcCtD
Sildenafil—Dermatitis—Etoposide—lung cancer	2.84e-05	0.000195	CcSEcCtD
Sildenafil—Headache—Etoposide—lung cancer	2.82e-05	0.000194	CcSEcCtD
Sildenafil—Flatulence—Doxorubicin—lung cancer	2.82e-05	0.000194	CcSEcCtD
Sildenafil—Chest pain—Methotrexate—lung cancer	2.81e-05	0.000193	CcSEcCtD
Sildenafil—Myalgia—Methotrexate—lung cancer	2.81e-05	0.000193	CcSEcCtD
Sildenafil—Arthralgia—Methotrexate—lung cancer	2.81e-05	0.000193	CcSEcCtD
Sildenafil—Tension—Doxorubicin—lung cancer	2.81e-05	0.000193	CcSEcCtD
Sildenafil—Vomiting—Paclitaxel—lung cancer	2.81e-05	0.000193	CcSEcCtD
Sildenafil—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	2.79e-05	0.000192	CcSEcCtD
Sildenafil—Rash—Paclitaxel—lung cancer	2.78e-05	0.000191	CcSEcCtD
Sildenafil—Dermatitis—Paclitaxel—lung cancer	2.78e-05	0.000191	CcSEcCtD
Sildenafil—Discomfort—Methotrexate—lung cancer	2.78e-05	0.000191	CcSEcCtD
Sildenafil—Nervousness—Doxorubicin—lung cancer	2.78e-05	0.000191	CcSEcCtD
Sildenafil—Back pain—Doxorubicin—lung cancer	2.77e-05	0.00019	CcSEcCtD
Sildenafil—Headache—Paclitaxel—lung cancer	2.77e-05	0.00019	CcSEcCtD
Sildenafil—Hypersensitivity—Docetaxel—lung cancer	2.76e-05	0.000189	CcSEcCtD
Sildenafil—Vision blurred—Doxorubicin—lung cancer	2.7e-05	0.000185	CcSEcCtD
Sildenafil—Asthenia—Docetaxel—lung cancer	2.69e-05	0.000184	CcSEcCtD
Sildenafil—Infection—Methotrexate—lung cancer	2.68e-05	0.000184	CcSEcCtD
Sildenafil—Nausea—Etoposide—lung cancer	2.68e-05	0.000184	CcSEcCtD
Sildenafil—Ill-defined disorder—Doxorubicin—lung cancer	2.66e-05	0.000182	CcSEcCtD
Sildenafil—Pruritus—Docetaxel—lung cancer	2.65e-05	0.000182	CcSEcCtD
Sildenafil—Nervous system disorder—Methotrexate—lung cancer	2.65e-05	0.000182	CcSEcCtD
Sildenafil—Anaemia—Doxorubicin—lung cancer	2.65e-05	0.000182	CcSEcCtD
Sildenafil—Agitation—Doxorubicin—lung cancer	2.63e-05	0.000181	CcSEcCtD
Sildenafil—Nausea—Paclitaxel—lung cancer	2.62e-05	0.00018	CcSEcCtD
Sildenafil—Skin disorder—Methotrexate—lung cancer	2.62e-05	0.00018	CcSEcCtD
Sildenafil—Hyperhidrosis—Methotrexate—lung cancer	2.61e-05	0.000179	CcSEcCtD
Sildenafil—Malaise—Doxorubicin—lung cancer	2.58e-05	0.000177	CcSEcCtD
Sildenafil—Vertigo—Doxorubicin—lung cancer	2.57e-05	0.000176	CcSEcCtD
Sildenafil—Anorexia—Methotrexate—lung cancer	2.57e-05	0.000176	CcSEcCtD
Sildenafil—Syncope—Doxorubicin—lung cancer	2.57e-05	0.000176	CcSEcCtD
Sildenafil—Leukopenia—Doxorubicin—lung cancer	2.56e-05	0.000176	CcSEcCtD
Sildenafil—Diarrhoea—Docetaxel—lung cancer	2.56e-05	0.000176	CcSEcCtD
Sildenafil—Palpitations—Doxorubicin—lung cancer	2.53e-05	0.000174	CcSEcCtD
Sildenafil—Hypotension—Methotrexate—lung cancer	2.52e-05	0.000173	CcSEcCtD
Sildenafil—Loss of consciousness—Doxorubicin—lung cancer	2.52e-05	0.000173	CcSEcCtD
Sildenafil—Cough—Doxorubicin—lung cancer	2.5e-05	0.000171	CcSEcCtD
Sildenafil—Convulsion—Doxorubicin—lung cancer	2.48e-05	0.00017	CcSEcCtD
Sildenafil—Dizziness—Docetaxel—lung cancer	2.48e-05	0.00017	CcSEcCtD
Sildenafil—Hypertension—Doxorubicin—lung cancer	2.47e-05	0.00017	CcSEcCtD
Sildenafil—Musculoskeletal discomfort—Methotrexate—lung cancer	2.46e-05	0.000169	CcSEcCtD
Sildenafil—Insomnia—Methotrexate—lung cancer	2.44e-05	0.000167	CcSEcCtD
Sildenafil—Myalgia—Doxorubicin—lung cancer	2.44e-05	0.000167	CcSEcCtD
Sildenafil—Chest pain—Doxorubicin—lung cancer	2.44e-05	0.000167	CcSEcCtD
Sildenafil—Arthralgia—Doxorubicin—lung cancer	2.44e-05	0.000167	CcSEcCtD
Sildenafil—Anxiety—Doxorubicin—lung cancer	2.43e-05	0.000167	CcSEcCtD
Sildenafil—Paraesthesia—Methotrexate—lung cancer	2.42e-05	0.000166	CcSEcCtD
Sildenafil—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	2.42e-05	0.000166	CcSEcCtD
Sildenafil—Discomfort—Doxorubicin—lung cancer	2.41e-05	0.000165	CcSEcCtD
Sildenafil—Dyspnoea—Methotrexate—lung cancer	2.41e-05	0.000165	CcSEcCtD
Sildenafil—Somnolence—Methotrexate—lung cancer	2.4e-05	0.000165	CcSEcCtD
Sildenafil—Dry mouth—Doxorubicin—lung cancer	2.38e-05	0.000164	CcSEcCtD
Sildenafil—Vomiting—Docetaxel—lung cancer	2.38e-05	0.000163	CcSEcCtD
Sildenafil—Dyspepsia—Methotrexate—lung cancer	2.37e-05	0.000163	CcSEcCtD
Sildenafil—Rash—Docetaxel—lung cancer	2.36e-05	0.000162	CcSEcCtD
Sildenafil—Dermatitis—Docetaxel—lung cancer	2.36e-05	0.000162	CcSEcCtD
Sildenafil—Decreased appetite—Methotrexate—lung cancer	2.35e-05	0.000161	CcSEcCtD
Sildenafil—Headache—Docetaxel—lung cancer	2.35e-05	0.000161	CcSEcCtD
Sildenafil—Oedema—Doxorubicin—lung cancer	2.34e-05	0.00016	CcSEcCtD
Sildenafil—Gastrointestinal disorder—Methotrexate—lung cancer	2.33e-05	0.00016	CcSEcCtD
Sildenafil—Fatigue—Methotrexate—lung cancer	2.33e-05	0.00016	CcSEcCtD
Sildenafil—Infection—Doxorubicin—lung cancer	2.32e-05	0.000159	CcSEcCtD
Sildenafil—Pain—Methotrexate—lung cancer	2.31e-05	0.000158	CcSEcCtD
Sildenafil—Shock—Doxorubicin—lung cancer	2.3e-05	0.000158	CcSEcCtD
Sildenafil—Nervous system disorder—Doxorubicin—lung cancer	2.29e-05	0.000157	CcSEcCtD
Sildenafil—Tachycardia—Doxorubicin—lung cancer	2.28e-05	0.000156	CcSEcCtD
Sildenafil—Skin disorder—Doxorubicin—lung cancer	2.27e-05	0.000156	CcSEcCtD
Sildenafil—Hyperhidrosis—Doxorubicin—lung cancer	2.26e-05	0.000155	CcSEcCtD
Sildenafil—Anorexia—Doxorubicin—lung cancer	2.23e-05	0.000153	CcSEcCtD
Sildenafil—Nausea—Docetaxel—lung cancer	2.22e-05	0.000153	CcSEcCtD
Sildenafil—Feeling abnormal—Methotrexate—lung cancer	2.22e-05	0.000153	CcSEcCtD
Sildenafil—Gastrointestinal pain—Methotrexate—lung cancer	2.21e-05	0.000151	CcSEcCtD
Sildenafil—Hypotension—Doxorubicin—lung cancer	2.18e-05	0.00015	CcSEcCtD
Sildenafil—Urticaria—Methotrexate—lung cancer	2.14e-05	0.000147	CcSEcCtD
Sildenafil—Abdominal pain—Methotrexate—lung cancer	2.13e-05	0.000146	CcSEcCtD
Sildenafil—Body temperature increased—Methotrexate—lung cancer	2.13e-05	0.000146	CcSEcCtD
Sildenafil—Musculoskeletal discomfort—Doxorubicin—lung cancer	2.13e-05	0.000146	CcSEcCtD
Sildenafil—Insomnia—Doxorubicin—lung cancer	2.11e-05	0.000145	CcSEcCtD
Sildenafil—Paraesthesia—Doxorubicin—lung cancer	2.1e-05	0.000144	CcSEcCtD
Sildenafil—Dyspnoea—Doxorubicin—lung cancer	2.08e-05	0.000143	CcSEcCtD
Sildenafil—Somnolence—Doxorubicin—lung cancer	2.08e-05	0.000143	CcSEcCtD
Sildenafil—Dyspepsia—Doxorubicin—lung cancer	2.06e-05	0.000141	CcSEcCtD
Sildenafil—Decreased appetite—Doxorubicin—lung cancer	2.03e-05	0.000139	CcSEcCtD
Sildenafil—Gastrointestinal disorder—Doxorubicin—lung cancer	2.02e-05	0.000138	CcSEcCtD
Sildenafil—Fatigue—Doxorubicin—lung cancer	2.01e-05	0.000138	CcSEcCtD
Sildenafil—Constipation—Doxorubicin—lung cancer	2e-05	0.000137	CcSEcCtD
Sildenafil—Pain—Doxorubicin—lung cancer	2e-05	0.000137	CcSEcCtD
Sildenafil—Hypersensitivity—Methotrexate—lung cancer	1.99e-05	0.000136	CcSEcCtD
Sildenafil—Asthenia—Methotrexate—lung cancer	1.94e-05	0.000133	CcSEcCtD
Sildenafil—Feeling abnormal—Doxorubicin—lung cancer	1.93e-05	0.000132	CcSEcCtD
Sildenafil—Gastrointestinal pain—Doxorubicin—lung cancer	1.91e-05	0.000131	CcSEcCtD
Sildenafil—Pruritus—Methotrexate—lung cancer	1.91e-05	0.000131	CcSEcCtD
Sildenafil—Urticaria—Doxorubicin—lung cancer	1.86e-05	0.000127	CcSEcCtD
Sildenafil—Abdominal pain—Doxorubicin—lung cancer	1.85e-05	0.000127	CcSEcCtD
Sildenafil—Body temperature increased—Doxorubicin—lung cancer	1.85e-05	0.000127	CcSEcCtD
Sildenafil—Diarrhoea—Methotrexate—lung cancer	1.85e-05	0.000127	CcSEcCtD
Sildenafil—Dizziness—Methotrexate—lung cancer	1.78e-05	0.000122	CcSEcCtD
Sildenafil—Hypersensitivity—Doxorubicin—lung cancer	1.72e-05	0.000118	CcSEcCtD
Sildenafil—Vomiting—Methotrexate—lung cancer	1.72e-05	0.000118	CcSEcCtD
Sildenafil—Rash—Methotrexate—lung cancer	1.7e-05	0.000117	CcSEcCtD
Sildenafil—Dermatitis—Methotrexate—lung cancer	1.7e-05	0.000117	CcSEcCtD
Sildenafil—Headache—Methotrexate—lung cancer	1.69e-05	0.000116	CcSEcCtD
Sildenafil—Asthenia—Doxorubicin—lung cancer	1.68e-05	0.000115	CcSEcCtD
Sildenafil—Pruritus—Doxorubicin—lung cancer	1.65e-05	0.000113	CcSEcCtD
Sildenafil—Nausea—Methotrexate—lung cancer	1.6e-05	0.00011	CcSEcCtD
Sildenafil—Diarrhoea—Doxorubicin—lung cancer	1.6e-05	0.00011	CcSEcCtD
Sildenafil—Dizziness—Doxorubicin—lung cancer	1.54e-05	0.000106	CcSEcCtD
Sildenafil—Vomiting—Doxorubicin—lung cancer	1.49e-05	0.000102	CcSEcCtD
Sildenafil—Rash—Doxorubicin—lung cancer	1.47e-05	0.000101	CcSEcCtD
Sildenafil—Dermatitis—Doxorubicin—lung cancer	1.47e-05	0.000101	CcSEcCtD
Sildenafil—Headache—Doxorubicin—lung cancer	1.46e-05	0.0001	CcSEcCtD
Sildenafil—Nausea—Doxorubicin—lung cancer	1.39e-05	9.52e-05	CcSEcCtD
Sildenafil—CYP2D6—Metabolism—HPGDS—lung cancer	4.25e-06	5.67e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—ENO2—lung cancer	4.25e-06	5.67e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—PPP2R1B—lung cancer	4.22e-06	5.63e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—HPGDS—lung cancer	4.21e-06	5.62e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—ENO2—lung cancer	4.21e-06	5.62e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—ENO1—lung cancer	4.19e-06	5.6e-05	CbGpPWpGaD
Sildenafil—ABCC5—Disease—PIK3CA—lung cancer	4.19e-06	5.6e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—PPP2R1B—lung cancer	4.18e-06	5.59e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	4.18e-06	5.58e-05	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—APOA1—lung cancer	4.15e-06	5.54e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism of lipids and lipoproteins—POMC—lung cancer	4.13e-06	5.51e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism of lipids and lipoproteins—ALB—lung cancer	4.13e-06	5.51e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—GSTT1—lung cancer	4.12e-06	5.5e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—STK11—lung cancer	4.1e-06	5.47e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—RRM1—lung cancer	4.08e-06	5.45e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—GSTA3—lung cancer	4.08e-06	5.45e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—GSTT1—lung cancer	4.08e-06	5.45e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—GCLC—lung cancer	4.07e-06	5.44e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—CYP2A6—lung cancer	4.07e-06	5.44e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—CYP2A6—lung cancer	4.03e-06	5.39e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—GCLC—lung cancer	4.03e-06	5.39e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—GSTP1—lung cancer	4.02e-06	5.37e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	4.02e-06	5.37e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—GSTP1—lung cancer	4.01e-06	5.36e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—PIK3CA—lung cancer	3.93e-06	5.25e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—MDM2—lung cancer	3.91e-06	5.23e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—CAT—lung cancer	3.91e-06	5.23e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—CAT—lung cancer	3.91e-06	5.22e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—RAF1—lung cancer	3.9e-06	5.21e-05	CbGpPWpGaD
Sildenafil—ABCC5—Disease—HRAS—lung cancer	3.88e-06	5.18e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—ERBB2—lung cancer	3.86e-06	5.15e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—ENO1—lung cancer	3.86e-06	5.15e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—lung cancer	3.85e-06	5.14e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—B4GALT5—lung cancer	3.84e-06	5.13e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—ENO1—lung cancer	3.83e-06	5.11e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	3.81e-06	5.09e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—PIK3CB—lung cancer	3.81e-06	5.09e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—MTOR—lung cancer	3.81e-06	5.09e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—ABCB1—lung cancer	3.81e-06	5.08e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—ABCB1—lung cancer	3.8e-06	5.07e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—GSTP1—lung cancer	3.79e-06	5.06e-05	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—PIK3CG—lung cancer	3.79e-06	5.06e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—CYP2E1—lung cancer	3.76e-06	5.03e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism of lipids and lipoproteins—ALB—lung cancer	3.76e-06	5.02e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—TYMS—lung cancer	3.74e-06	4.99e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—GSTA4—lung cancer	3.73e-06	4.99e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—TYMS—lung cancer	3.73e-06	4.98e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—NQO1—lung cancer	3.72e-06	4.97e-05	CbGpPWpGaD
Sildenafil—ABCC5—Disease—IL6—lung cancer	3.71e-06	4.96e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—GSTM1—lung cancer	3.7e-06	4.94e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—CAT—lung cancer	3.69e-06	4.93e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—GSTM1—lung cancer	3.69e-06	4.93e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism of lipids and lipoproteins—EP300—lung cancer	3.67e-06	4.9e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—CXCL8—lung cancer	3.66e-06	4.89e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	3.64e-06	4.87e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—GSTA2—lung cancer	3.64e-06	4.86e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—HRAS—lung cancer	3.64e-06	4.86e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	3.61e-06	4.82e-05	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—POMC—lung cancer	3.61e-06	4.82e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—ABCB1—lung cancer	3.59e-06	4.79e-05	CbGpPWpGaD
Sildenafil—ADORA2A—GPCR downstream signaling—AKT1—lung cancer	3.54e-06	4.72e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—TYMS—lung cancer	3.53e-06	4.71e-05	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—CREBBP—lung cancer	3.51e-06	4.69e-05	CbGpPWpGaD
Sildenafil—ABCC5—Metabolism—PIK3CA—lung cancer	3.51e-06	4.69e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—GSTA1—lung cancer	3.51e-06	4.69e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—CYP1A1—lung cancer	3.5e-06	4.68e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—CASP3—lung cancer	3.5e-06	4.68e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—IL2—lung cancer	3.5e-06	4.67e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—CYP1A1—lung cancer	3.5e-06	4.67e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—GSTM1—lung cancer	3.48e-06	4.65e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—IL6—lung cancer	3.48e-06	4.65e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—ERCC2—lung cancer	3.47e-06	4.64e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—ABCC3—lung cancer	3.47e-06	4.64e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—ERCC2—lung cancer	3.47e-06	4.63e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—CYP2E1—lung cancer	3.46e-06	4.62e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—CYP2E1—lung cancer	3.43e-06	4.58e-05	CbGpPWpGaD
Sildenafil—ABCC5—Disease—AKT1—lung cancer	3.43e-06	4.58e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—NQO1—lung cancer	3.42e-06	4.57e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—CCND1—lung cancer	3.41e-06	4.55e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—JUN—lung cancer	3.4e-06	4.54e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—NQO1—lung cancer	3.39e-06	4.53e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—AKR1C1—lung cancer	3.36e-06	4.49e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—STK11—lung cancer	3.35e-06	4.48e-05	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—PIK3CD—lung cancer	3.33e-06	4.45e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	3.32e-06	4.44e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—MMP9—lung cancer	3.31e-06	4.42e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—CDKN1A—lung cancer	3.3e-06	4.41e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	3.29e-06	4.4e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—PTEN—lung cancer	3.29e-06	4.4e-05	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—ALB—lung cancer	3.29e-06	4.39e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—ERCC2—lung cancer	3.28e-06	4.38e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—UGT1A1—lung cancer	3.26e-06	4.36e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—AKT1—lung cancer	3.21e-06	4.29e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—lung cancer	3.15e-06	4.2e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—GNG11—lung cancer	3.15e-06	4.2e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—EP300—lung cancer	3.14e-06	4.19e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—GSTP1—lung cancer	3.1e-06	4.14e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—STK11—lung cancer	3.08e-06	4.12e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—STK11—lung cancer	3.06e-06	4.08e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—SRC—lung cancer	3.05e-06	4.08e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—CAT—lung cancer	3.02e-06	4.03e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—APOA1—lung cancer	3.01e-06	4.01e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism of lipids and lipoproteins—EP300—lung cancer	3e-06	4.01e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—APOA1—lung cancer	3e-06	4.01e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—ALDOA—lung cancer	3e-06	4e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—VEGFA—lung cancer	2.97e-06	3.97e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—STAT3—lung cancer	2.94e-06	3.93e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—ABCB1—lung cancer	2.94e-06	3.92e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—NRAS—lung cancer	2.94e-06	3.92e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—NCOA3—lung cancer	2.91e-06	3.89e-05	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—PIK3CB—lung cancer	2.9e-06	3.88e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—TYMS—lung cancer	2.88e-06	3.85e-05	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—PTGS2—lung cancer	2.88e-06	3.84e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—lung cancer	2.87e-06	3.83e-05	CbGpPWpGaD
Sildenafil—ABCC5—Metabolism—AKT1—lung cancer	2.87e-06	3.83e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—GSTP1—lung cancer	2.85e-06	3.81e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—GSTM1—lung cancer	2.85e-06	3.81e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—APOA1—lung cancer	2.83e-06	3.79e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—ADCY1—lung cancer	2.83e-06	3.78e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—ABCG2—lung cancer	2.83e-06	3.78e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—GSTP1—lung cancer	2.83e-06	3.78e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—MAPK3—lung cancer	2.81e-06	3.76e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—CAT—lung cancer	2.78e-06	3.71e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—HPGDS—lung cancer	2.78e-06	3.71e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—ENO2—lung cancer	2.78e-06	3.71e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—PPP2R1B—lung cancer	2.76e-06	3.68e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—CAT—lung cancer	2.75e-06	3.68e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—PIK3CG—lung cancer	2.74e-06	3.67e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—PIK3CG—lung cancer	2.74e-06	3.66e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism of lipids and lipoproteins—EP300—lung cancer	2.74e-06	3.66e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—MYC—lung cancer	2.74e-06	3.65e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	2.71e-06	3.62e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—CYP1A1—lung cancer	2.7e-06	3.61e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—ABCB1—lung cancer	2.7e-06	3.61e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—GSTT1—lung cancer	2.69e-06	3.6e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—ERCC2—lung cancer	2.68e-06	3.58e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—ABCB1—lung cancer	2.68e-06	3.58e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—EGFR—lung cancer	2.68e-06	3.57e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—GCLC—lung cancer	2.66e-06	3.55e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—CYP2A6—lung cancer	2.66e-06	3.55e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—TYMS—lung cancer	2.65e-06	3.54e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—TYMS—lung cancer	2.63e-06	3.51e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—GSTM1—lung cancer	2.62e-06	3.5e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—POMC—lung cancer	2.61e-06	3.49e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—POMC—lung cancer	2.61e-06	3.48e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—GSTM1—lung cancer	2.6e-06	3.47e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—PIK3CG—lung cancer	2.59e-06	3.46e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—CREBBP—lung cancer	2.54e-06	3.4e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—CREBBP—lung cancer	2.54e-06	3.39e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—KRAS—lung cancer	2.53e-06	3.38e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—ENO1—lung cancer	2.52e-06	3.37e-05	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—PTEN—lung cancer	2.51e-06	3.35e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—CYP1A1—lung cancer	2.49e-06	3.32e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—ERCC2—lung cancer	2.47e-06	3.29e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—CYP1A1—lung cancer	2.46e-06	3.29e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—POMC—lung cancer	2.46e-06	3.29e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—ERCC2—lung cancer	2.44e-06	3.27e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—PIK3CD—lung cancer	2.41e-06	3.22e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—PIK3CD—lung cancer	2.41e-06	3.22e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—CREBBP—lung cancer	2.4e-06	3.2e-05	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—EP300—lung cancer	2.39e-06	3.2e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—ALB—lung cancer	2.38e-06	3.18e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—ALB—lung cancer	2.38e-06	3.17e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—PIK3CA—lung cancer	2.32e-06	3.1e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—APOA1—lung cancer	2.32e-06	3.1e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—PIK3CD—lung cancer	2.27e-06	3.04e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—CYP2E1—lung cancer	2.26e-06	3.02e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—TP53—lung cancer	2.25e-06	3e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—ALB—lung cancer	2.25e-06	3e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—NQO1—lung cancer	2.24e-06	2.99e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	2.22e-06	2.97e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—HRAS—lung cancer	2.15e-06	2.87e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—APOA1—lung cancer	2.13e-06	2.85e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—PIK3CG—lung cancer	2.12e-06	2.83e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—APOA1—lung cancer	2.11e-06	2.82e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—PIK3CB—lung cancer	2.1e-06	2.81e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—PIK3CB—lung cancer	2.1e-06	2.8e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—PTGS2—lung cancer	2.08e-06	2.78e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—PTGS2—lung cancer	2.08e-06	2.78e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—IL6—lung cancer	2.06e-06	2.75e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	2.02e-06	2.7e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—STK11—lung cancer	2.02e-06	2.69e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—POMC—lung cancer	2.02e-06	2.69e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—PIK3CB—lung cancer	1.98e-06	2.65e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—PTGS2—lung cancer	1.96e-06	2.62e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—CREBBP—lung cancer	1.96e-06	2.62e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—PIK3CG—lung cancer	1.95e-06	2.6e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—PIK3CG—lung cancer	1.93e-06	2.58e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—AKT1—lung cancer	1.9e-06	2.53e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—GSTP1—lung cancer	1.87e-06	2.49e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—PIK3CD—lung cancer	1.86e-06	2.49e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—POMC—lung cancer	1.85e-06	2.48e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—POMC—lung cancer	1.84e-06	2.45e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—ALB—lung cancer	1.84e-06	2.45e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—PTEN—lung cancer	1.82e-06	2.43e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—CAT—lung cancer	1.82e-06	2.43e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—PTEN—lung cancer	1.81e-06	2.42e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—CREBBP—lung cancer	1.81e-06	2.41e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—CREBBP—lung cancer	1.79e-06	2.39e-05	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—PIK3CA—lung cancer	1.77e-06	2.36e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—ABCB1—lung cancer	1.77e-06	2.36e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—TYMS—lung cancer	1.73e-06	2.32e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—EP300—lung cancer	1.73e-06	2.31e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—EP300—lung cancer	1.73e-06	2.31e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—GSTM1—lung cancer	1.71e-06	2.29e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—PTEN—lung cancer	1.71e-06	2.29e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—PIK3CD—lung cancer	1.71e-06	2.29e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—PIK3CD—lung cancer	1.7e-06	2.27e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—ALB—lung cancer	1.69e-06	2.26e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—ALB—lung cancer	1.68e-06	2.24e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—EP300—lung cancer	1.63e-06	2.18e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—CYP1A1—lung cancer	1.63e-06	2.17e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—PIK3CB—lung cancer	1.62e-06	2.17e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—ERCC2—lung cancer	1.61e-06	2.15e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—PTGS2—lung cancer	1.61e-06	2.15e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—PIK3CB—lung cancer	1.49e-06	1.99e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—PIK3CB—lung cancer	1.48e-06	1.98e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—PTGS2—lung cancer	1.48e-06	1.97e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—PTGS2—lung cancer	1.47e-06	1.96e-05	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—AKT1—lung cancer	1.45e-06	1.93e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—PTEN—lung cancer	1.4e-06	1.87e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—APOA1—lung cancer	1.39e-06	1.86e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—EP300—lung cancer	1.34e-06	1.79e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—PTEN—lung cancer	1.29e-06	1.72e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—PIK3CA—lung cancer	1.28e-06	1.71e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—PIK3CA—lung cancer	1.28e-06	1.71e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—PTEN—lung cancer	1.28e-06	1.71e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—PIK3CG—lung cancer	1.27e-06	1.7e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—EP300—lung cancer	1.23e-06	1.64e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—EP300—lung cancer	1.22e-06	1.63e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—POMC—lung cancer	1.21e-06	1.62e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—PIK3CA—lung cancer	1.21e-06	1.61e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—CREBBP—lung cancer	1.18e-06	1.58e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—PIK3CD—lung cancer	1.12e-06	1.49e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—ALB—lung cancer	1.1e-06	1.48e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—AKT1—lung cancer	1.05e-06	1.4e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—AKT1—lung cancer	1.05e-06	1.4e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—PIK3CA—lung cancer	9.89e-07	1.32e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—AKT1—lung cancer	9.87e-07	1.32e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—PIK3CB—lung cancer	9.76e-07	1.3e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—PTGS2—lung cancer	9.67e-07	1.29e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—PIK3CA—lung cancer	9.1e-07	1.21e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—PIK3CA—lung cancer	9.02e-07	1.2e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—PTEN—lung cancer	8.43e-07	1.13e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—AKT1—lung cancer	8.08e-07	1.08e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—EP300—lung cancer	8.04e-07	1.07e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—AKT1—lung cancer	7.43e-07	9.93e-06	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—AKT1—lung cancer	7.37e-07	9.84e-06	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—PIK3CA—lung cancer	5.95e-07	7.94e-06	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—AKT1—lung cancer	4.86e-07	6.49e-06	CbGpPWpGaD
